Cargando…
Possibilities and challenges for developing a successful vaccine for leishmaniasis
Leishmaniasis is a vector-borne disease caused by different species of protozoan parasites of the genus Leishmania. It is a major health problem yet neglected tropical diseases, with approximately 350 million people worldwide at risk and more than 1.5 million infections occurring each year. Leishman...
Autores principales: | Srivastava, Saumya, Shankar, Prem, Mishra, Jyotsna, Singh, Sarman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866332/ https://www.ncbi.nlm.nih.gov/pubmed/27175732 http://dx.doi.org/10.1186/s13071-016-1553-y |
Ejemplares similares
-
Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India
por: Srivastava, Saumya, et al.
Publicado: (2017) -
Multiplex PCR assay for simultaneous detection and differentiation of Entamoeba histolytica, Giardia lamblia, and Salmonella spp. in the municipality-supplied drinking water
por: Shankar, Prem, et al.
Publicado: (2019) -
De Novo Whole-Genome Sequence and Annotation of a Leishmania Strain Isolated from a Case of Post-Kala-Azar Dermal Leishmaniasis
por: Gupta, Anil Kumar, et al.
Publicado: (2015) -
Journal of Laboratory Physicians (JLP): Success Story Despite Many Challenges
por: Singh, Sarman
Publicado: (2011) -
Cutaneous leishmaniasis in Bikaner, India: Clinicoepidemiological profile; parasite identification using conventional, molecular methods and CL Detect™ rapid test, a new Food and Drug Administration-approved test
por: Rajni, Ekadashi, et al.
Publicado: (2019)